FITLIFE BRANDS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
FITLIFE BRANDS, INC. (FTLF) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $10.85 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $15.21.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.00.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $16.63, a 74.14% increase from fiscal 2023.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $9.55, a 38.98% decline from fiscal 2022.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $15.65, a 211.13% increase from fiscal 2021.
- FITLIFE BRANDS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $5.03.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 1 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.85 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $15.21 10-Q · filed 2026-05-14 | ||||||
| 2025-12-31 | $18.73 10-Q · filed 2026-08-13 | ||||||
| 2025-09-30 | $18.73 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | $16.63 10-K · filed 2026-03-31 | ||||||
| 2024-09-30 | $33.20 10-Q · filed 2024-11-14 | ||||||
| 2024-08-31 | $33.20 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | $9.55 10-K · filed 2025-03-27 | $19.10 10-K · filed 2024-03-29 | |||||
| 2023-08-31 | $18.15 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | $18.15 10-Q · filed 2023-11-13 | $0.00 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | $15.65 10-K · filed 2024-03-29 | ||||||
| 2022-09-30 | $15.65 10-Q · filed 2022-11-10 | ||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-10-14 | ||||||
| 2021-12-31 | $5.03 10-K · filed 2023-03-24 | ||||||
| 2021-09-30 | $20.13 10-Q · filed 2021-11-12 | ||||||
| 2021-06-30 | $20.13 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | $20.13 10-Q · filed 2021-05-14 | ||||||
| 2020-12-31 | $0.00 10-K/A · filed 2022-10-13 | ||||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | ||||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | ||||||
| 2019-12-31 | $6.85 10-K/A · filed 2022-10-13 | ||||||
| 2019-09-30 | $6.85 10-Q · filed 2019-11-12 | ||||||
| 2019-06-30 | $6.85 10-Q · filed 2019-08-09 | ||||||
| 2018-12-31 | $3.50 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |